本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Artivion

24.63
+0.47001.95%
成交量:13.42万
成交额:328.55万
市值:10.36亿
市盈率:-76.97
高:24.63
开:24.27
低:24.16
收:24.16
数据加载中...

公司资料

公司名字:
Artivion
交易所:
NYSE
成立时间:
1984
员工人数:
1600
公司地址:
1655 Roberts Boulevard NW,Kennesaw,Georgia,United States
邮编:
30144
传真:
- -
简介:
Artivion, Inc.于 1984 年在佛罗里达州注册成立,并于2022年1月1日将其注册地址从佛罗里达州更改为特拉华州,是生产,加工和分销医疗器械和植入式人体组织的领先企业,专注于主动脉修复。 他们的医疗设备和加工组织主要包括四个产品系列:BioGlue外科胶粘剂(“BioGlue”); On-X机械心脏瓣膜和手术产品; JOTEC血管内和外科产品; 以及包括CryoValve SG肺心脏瓣膜(“CryoValve SGPV”)和CryoPatch SG肺心脏贴片(“CryoPatch SG”)在内的心脏和血管人体组织,两者均使用其专有的SynerGraft技术加工。 其他产品包括CardioGenesis心脏激光疗法,PerClot和PhotoFixTM。

董事

名称
职位
J. Patrick Mackin
Director, President and Chief Executive Officer
Daniel J. Bevevino
Director
Harvey Morgan
Director
James W. Bullock
Director
Jeffrey H. Burbank
Director
Jon W. Salveson
Director
Marna P. Borgstrom
Director
Ronald D. McCall
Director
Thomas F. Ackerman
Director

股东

名称
职位
J. Patrick Mackin
Director, President and Chief Executive Officer
D. Ashley Lee
Executive Vice President, Chief Operating Officer,Chief Financial Officer
Jean F. Holloway
Senior Vice President, General Counsel, Chief Compliance Officer, and Secretary
John E. Davis
Senior Vice President, Global Sales and Marketing
Michael S. Simpson
Senior Vice President, Regulatory Affairs and Quality Assurance
Amy D. Horton
Vice President and Chief Accounting Officer
Dennis B. Maier
Vice President, Operations
F. Peter Barthold
Vice President, Research and Development
Matthew A. Getz
Vice President, Human Resources
Scott B. Capps
Vice President, Clinical Research